| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aptose Biosciences Inc. | Sr VP and CFO | Employee Stock Option (Right to Buy) | 55,000 | 05 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| APTOF | Aptose Biosciences Inc. | 05 Feb 2024 | 1 | $0 | 4 | Sr VP and CFO | 07 Feb 2024, 18:06 |
| APTOF | Aptose Biosciences Inc. | 19 Jan 2023 | 2 | $0 | 4 | SR VP & Chief Fin. Officer | 23 Jan 2023, 18:57 |
| APTOF | Aptose Biosciences Inc. | 19 Sep 2022 | 1 | +$6,775 | 4 | SR VP & Chief Fin. Officer | 21 Sep 2022, 18:06 |
| APTOF | Aptose Biosciences Inc. | 27 Jun 2022 | 1 | $0 | 4 | SR VP & Chief Fin. Officer | 28 Jun 2022, 16:16 |
| APTOF | Aptose Biosciences Inc. | 27 Jun 2022 | 0 | $0 | 3 | SR VP & Chief Fin. Officer | 28 Jun 2022, 16:12 |